Development and validation of a machine learning model to predict the risk of lymph node metastasis in early-stage supraglottic laryngeal cancer.
Source check: Source checked. Not independent scientific confirmation.
Finding: Original full text, Methods/Results: six ML models predicted pathology-confirmed lymph-node metastasis in early supraglottic cancer; SEER development and separate Fujian hospital validation (n=78), external AUC .80. Retrospective external validation. The reviewed source supports this bounded result; external generalization, causal effects, and sustained operational impact remain unestablished where the source reports retrospective or internal evaluation.
Technology: The source applies machine-learning analysis to the stated study outcome: Original full text, Methods/Results: six ML models predicted pathology-confirmed lymph-node metastasis in early supraglottic cancer; SEER development and separate Fujian hospital validation (n=78), external AUC .
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Original full text, Methods/Results: six ML models predicted pathology-confirmed lymph-node metastasis in early supraglottic cancer; SEER development and separate Fujian hospital validation (n=78), external AUC .
- Test and result
- Methods and Results/proof passages support the result and scope summarized in reason.
- Limitation / still unknown
- Methods/Results specify cohort, reference/outcome, split or experimental comparator and limitations.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2025.1525414/full · https://europepmc.org/article/MED/40018413)
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.